# |
Name |
|
Stock Price |
Change |
Price (30 days) | 52W low/high | Sector |
---|
The Clinical Trials company in Switzerland with the highest Free Cash Flow Yield is AC Immune S.A. (NasdaqGM: ACIU) at 23.68%.
The Clinical Trials company in Switzerland with the lowest Free Cash Flow Yield is MoonLake Immunotherapeutics (NasdaqCM: MLTX) at None.
The top 10 Clinical Trials companies in Switzerland by Free Cash Flow Yield are AC Immune S.A., Basilea Pharmaceutica AG, Roche Holding AG, Novartis AG, IVF Hartmann Holding AG, Kuros Biosciences AG, Medacta Group S.A., Siegfried Holding AG, Bachem Holding AG and Oculis Holding AG.
The bottom 10 Clinical Trials companies in Switzerland by Free Cash Flow Yield are MoonLake Immunotherapeutics, NLS Pharmaceutics AG, Idorsia Ltd, Addex Therapeutics Ltd, Molecular Partners AG, ADC Therapeutics S.A., Santhera Pharmaceuticals Holding AG, CRISPR Therapeutics AG, Oculis Holding AG and Bachem Holding AG.